GREENOAKS CAPITAL PARTNERS LLC

Q4 2021 13F Holdings Report, Stock Holdings

Signature - Title
Patrick Lai - CFO & CCO
Location
Orinda, CA
Holdings as of
31 Dec 2021
Value $
$4,052,075,000
Num holdings
15
Filing time
14 Feb 2022, 16:06:51 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included CPNG, TOST, SE, CLOV, and UPWK.
Previous filing
Q3 2021 - 15 Nov 2021
Next filing
Q1 2022 - 16 May 2022
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q4 compared to 2021 Q3 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Patrick Lai CFO & CCO San Francisco, California 14 Feb 2022

Note: The position in the shares of Class A Common Stock of Clover Health Investments, Corp. ("Clover") reported in this Form 13F Holdings Report and the Form 13F Holdings Reports filed by the Reporting Person for the quarters ended March 31, 2021, June 30, 2021 and September 30, 2021 were held in the form of shares of Class B Common Stock of Clover which are convertible into the shares of Class A Common Stock at the option of the holder and under certain other circumstances provided for in Clover's certificate of incorporation.